Concepedia

Barbara Pro

BP

156

Publications

14.6K

Citations

58

H-Index

2001

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Northwestern University

Memorial Sloan Kettering Cancer Center

Washington University in St. Louis

City of Hope

Barbara Pro is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and immunotherapy.

Top concepts

Publications per year

2001–2023

156

Publications

156

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

Barbara Pro, Ranjana H. Advani, Pauline Brice et al. · Journal of Clinical Oncology · 2012 · 979 citations · Full text

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

Massimo Federico, Monica Bellei, Luigi Marcheselli et al. · Journal of Clinical Oncology · 2009 · 736 citations

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

Bertrand Coiffier, Barbara Pro, H. Miles Prince et al. · Journal of Clinical Oncology · 2012 · 664 citations

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

Owen A. O’Connor, Barbara Pro, Lauren Pinter‐Brown et al. · Journal of Clinical Oncology · 2011 · 630 citations · Full text

Rows per page

1–5 of 156